Good:
+ likely 90% effective if we use optimal dosing
+ no significant side effective. Looks better than Pfizer or Moderna.
+ already pre-produced at huge scale, 3 Bln doses in 2021
+ easy to store and administer, just regular fridge required
+ several times cheaper than mRNA
+ more traditional vaccine than novel mRNA, less tail risk in production and scaling up the process
Not good:
- two doses, efficient one month after first injection
- likely public will be confused about efficiency due to dosing regime